Project: Evaluation of a candidate therapeutic vaccine for chronic HCV infection.
- project duration
- 01-MAY-01 – 30-JUL-01
- The safety and immunogenicity of a candidate therapeutic vaccine based on the envelope 1 (E1) protein of HCV are evaluated in different study groups. Three doses of vaccine will be administered local and general side effects are monitored cellular and humoral immune responses are quantified.